neuropsychiatric disorders

BOSTON, December 12, 2025 — Contineum Therapeutics, Inc. announced the pricing of an upsized $90.0 million public offering of...

NEW YORK, November 6, 2025 — LB Pharmaceuticals Inc. (NASDAQ: LBRX), a clinical-stage biopharmaceutical company focused on developing therapies...